These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10810634)

  • 21. Engineered delta ribozymes can simultaneously knock down the expression of the genes encoding uracil phosphoribosyltransferase and hypoxanthine-xanthine-guanine phosphoribosyltransferase in Toxoplasma gondii.
    Sheng J; Al-Anouti F; Ananvoranich S
    Int J Parasitol; 2004 Mar; 34(3):253-63. PubMed ID: 15003487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribozyme expression systems.
    Sano M; Taira K
    Methods Mol Biol; 2004; 252():195-207. PubMed ID: 15017050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of new hairpin ribozymes with replaced domains.
    Komatsu Y; Kanzaki I; Koizumi M; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):223-4. PubMed ID: 8841632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribozymes: killing the messenger.
    Barinaga M
    Science; 1993 Dec; 262(5139):1512-4. PubMed ID: 8248799
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme.
    Klein D; Ricordi C; Pugliese A; Pastori RL
    Hum Gene Ther; 2000 May; 11(7):1033-45. PubMed ID: 10811232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationships of hammerhead ribozymes: from understanding to applications.
    Sigurdsson ST; Eckstein F
    Trends Biotechnol; 1995 Aug; 13(8):286-9. PubMed ID: 7662303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and functional aspects of catalytic RNAs.
    Castanotto D; Rossi JJ; Deshler JO
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitis virus nucleocapsid mRNA.
    Callison SA; Hilt DA; Jackwood MW
    Avian Dis; 2005 Mar; 49(1):159-63. PubMed ID: 15839432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
    James H; Mills K; Gibson I
    Leukemia; 1996 Jun; 10(6):1054-64. PubMed ID: 8667643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.
    Xu ZD; Oey L; Mohan S; Kawachi MH; Lee NS; Rossi JJ; Fujita-Yamaguchi Y
    Endocrinology; 1999 May; 140(5):2134-44. PubMed ID: 10218964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of tetracycline inducible self-cleaving ribozymes as synthetic devices for gene regulation in yeast.
    Wittmann A; Suess B
    Mol Biosyst; 2011 Aug; 7(8):2419-27. PubMed ID: 21603688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.